BackCartesian Growth II Overview
Cartesian Growth Corp II - Ordinary Shares - Class A

Cartesian Growth II Return on Equity

Cartesian Growth II (RENE) has a ROE of -1.95%, below the sector sector average of 11.85%.

Get informed when a big investor buys or sells

+ Follow

ROE

-1.95%

Return on Equity

-1.95%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Cartesian Growth II (RENE) FAQ

The latest ROE for RENE is -1.95%. That is below the sector sector average of 11.85%. Investors often review this figure alongside Cartesian Growth II's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, RENE currently prints -1.95% for ROE, while the sector average sits near 11.85%. That is roughly 116.4% below the sector mean. Large gaps often invite a closer look at Cartesian Growth II's growth, margins, and balance sheet.

Return on Equity shows how effectively Cartesian Growth II converts resources into returns. At -1.95%, RENE may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting RENE's ROE (-1.95%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.